María‐Belén Vídriales

Complejo Hospitalario de Salamanca — Spain

Medicine · Health Sciences

63h-index14.0kcitations281works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(126), Multiple Myeloma Research and Treatments(110), Chronic Lymphocytic Leukemia Research(45), Acute Lymphoblastic Leukemia research(38), Protein Degradation and Inhibitors(36)

Publications278 total

Erratum: Quizartinib for Newly Diagnosed <i>FLT3</i> -Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study
Journal of Clinical Oncology·2025
Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation
Clinical Lymphoma Myeloma & Leukemia·2025Open Access
A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study
Haematologica·2025Open Access
Clinical impact of FLT3 microclones on outcomes in patients with newly diagnosed FLT3-ITD negative AML: A subanalysis from the pethema quiwi trial
Blood·2025Open Access
Real-world outcomes of FLAG-ida salvage therapy in relapsed/refractory AML and validation of the salflage score: A pethema registry study
Blood·2025Open Access
Prognosis of FLT3 ligand level in newly diagnosed FLT3-ITD negative Acute Myeloid Leukemia patients enrolled in the pethema QUIWI trial
Blood·2025Open Access
Measurable residual disease (MRD) assessment as an early end point oftreatment efficacy in acute myeloid leukemia (AML): A pethema studyof 2,623 patients (Pts) treated with intensive therapy
Blood·2025Open Access
Quizartinib for Newly Diagnosed <i>FLT3</i> -Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study
Journal of Clinical Oncology·2025Open Access
Enfermedad medible residual en hematología: un objetivo terapéutico
Revista Sangre·2025Open Access
#3944 Natural killer subpopulations in kidney transplant patients with BK viruria
Nephrology Dialysis Transplantation·2025Open Access
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry
Leukemia·2025Open Access
Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience
Transplantation and Cellular Therapy·2025
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups
Cancers·2024· 3 citedOpen Access
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia
Biomarker Research·2024· 2 citedOpen Access
Blast Transformation of Chronic Myeloid Leukemia Driven by Acquisition of t(8;21)(q22;q22)/RUNX1::RUNX1T1: Selecting Optimal Treatment Based on Clinical and Molecular Findings
Biomedicines·2024Open Access
Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia
Blood Neoplasia·2024· 2 citedOpen Access
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry
Cancer·2024· 2 cited
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)
EClinicalMedicine·2024· 2 citedOpen Access
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Blood Cancer Journal·2024· 9 citedOpen Access
Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient
Biomedicines·2023· 3 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Jesús F. San Miguel(38), Alberto Órfão(31), Bruno Paiva(25), María‐Victoria Mateos(20), Ramón García‐Sánz(17), Juan José Lahuerta(17), Norma C. Gutiérrez(16), Albert Oriol(13), Joaquín Martínez‐López(12), Noemí Puig(11), Marcos González(11), Luis Palomera(10), Jacques J. M. van Dongen(9), Alejandro Martı́n(9), Javier de la Rubia(9), Joan Bladé(9), Enrique M. Ocio(9), Juan Flores‐Montero(8), Alfonso García de Coca(8), Felipe de Arriba(8)